Medable Raises $78M to Expand Decentralized Clinical Trials Platform for Patient-Centered Drug Development -
What You Should Know: – Medable, Inc., a Palo Alto, CA-based global platform for decentralized clinical trials today announced $78M in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating the industry’s shift to patient-centered drug development. The funding was led by Sapphire Ventures, along with new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD, Inc., and Streamlined Ventures. – This...
Source: hitconsultant.net